{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:13:29Z","timestamp":1774260809514,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T00:00:00Z","timestamp":1415664000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00253-014-6147-z","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T15:37:27Z","timestamp":1415979447000},"page":"667-680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity"],"prefix":"10.1007","volume":"99","author":[{"given":"Ziyin","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changjiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingmin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyu","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liancheng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,11]]},"reference":[{"issue":"2","key":"6147_CR1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-1759(96)00243-8","volume":"202","author":"H Asanuma","year":"1997","unstructured":"Asanuma H, Thompson AH, Iwasaki T, Sato Y, Inaba Y, Aizawa C, Kurata T, Tamura S (1997) Isolation and characterization of mouse nasal-associated lymphoid tissue. J Immunol Methods 202(2):123\u2013131","journal-title":"J Immunol Methods"},{"key":"6147_CR2","volume-title":"Short protocols in molecular biology: a compendium of methods from Current protocols in molecular biology","author":"FM Ausubel","year":"1989","unstructured":"Ausubel FM (1989) Short protocols in molecular biology: a compendium of methods from Current protocols in molecular biology. Greene Pub Associates and Wiley-Interscience, New York"},{"issue":"4","key":"6147_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2217\/fmb.14.7","volume":"9","author":"M Bassetti","year":"2014","unstructured":"Bassetti M, Villa G, Pecori D (2014) Antibiotic-resistant Pseudomonas aeruginosa: focus on care in patients receiving assisted ventilation. Future Microbiol 9(4):465\u2013474. doi: 10.2217\/fmb.14.7","journal-title":"Future Microbiol"},{"key":"6147_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1465-9921-8-57","volume":"8","author":"U Baumann","year":"2007","unstructured":"Baumann U, Gocke K, Gewecke B, Freihorst J, von Specht BU (2007) Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I\/II study. Respir Res 8:57. doi: 10.1186\/1465-9921-8-57","journal-title":"Respir Res"},{"issue":"11","key":"6147_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jradio.2011.09.004","volume":"92","author":"F Benoudiba","year":"2011","unstructured":"Benoudiba F, Toulgoat F, Sarrazin JL (2011) Skull base osteomyelitis. J Radiol 92(11):987\u2013994. doi: 10.1016\/j.jradio.2011.09.004","journal-title":"J Radiol"},{"issue":"5","key":"6147_CR6","doi-asserted-by":"publisher","first-page":"DC26","DOI":"10.7860\/JCDR\/2014\/7483.4383","volume":"8","author":"I Biswal","year":"2014","unstructured":"Biswal I, Arora BS, Kasana D, Neetushree (2014) Incidence of multidrug resistant pseudomonas aeruginosa isolated from burn patients and environment of teaching institution. J Clin Diagn Res 8(5):DC26\u2013DC29. doi: 10.7860\/JCDR\/2014\/7483.4383","journal-title":"J Clin Diagn Res"},{"issue":"2","key":"6147_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4021\/jocmr777w","volume":"4","author":"AR Caldas","year":"2012","unstructured":"Caldas AR, Brandao M, Paula FS, Castro E, Farinha F, Marinho A (2012) Hypertrophic cranial pachymeningitis and skull base osteomyelitis by pseudomonas aeruginosa: case report and review of the literature. J Clin Med Res 4(2):138\u2013144. doi: 10.4021\/jocmr777w","journal-title":"J Clin Med Res"},{"issue":"9","key":"6147_CR8","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.4049\/jimmunol.171.9.4552","volume":"171","author":"M Chieppa","year":"2003","unstructured":"Chieppa M, Bianchi G, Doni A, Del Prete A, Sironi M, Laskarin G, Monti P, Piemonti L, Biondi A, Mantovani A, Introna M, Allavena P (2003) Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J Immunol 171(9):4552\u20134560","journal-title":"J Immunol"},{"issue":"2","key":"6147_CR9","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1128\/Iai.74.2.968-974.2006","volume":"74","author":"AW Cripps","year":"2006","unstructured":"Cripps AW, Peek K, Dunkley M, Vento K, Marjason JK, McIntyre ME, Sizer P, Croft D, Sedlak-Weinstein L (2006) Safety and immunogenicity of an oral inactivated whole-cell Pseudomonas aeruginosa vaccine administered to healthy human subjects. Infect Immun 74(2):968\u2013974. doi: 10.1128\/Iai.74.2.968-974.2006","journal-title":"Infect Immun"},{"issue":"9","key":"6147_CR10","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1128\/JCM. 43.9.4680-4683.2005","volume":"43","author":"SH Silva da","year":"2005","unstructured":"da Silva SH, Colombo AL, Blotta MH, Queiroz-Telles F, Lopes JD, de Camargo ZP (2005) Diagnosis of neuroparacoccidioidomycosis by detection of circulating antigen and antibody in cerebrospinal fluid. J Clin Microbiol 43(9):4680\u20134683. doi: 10.1128\/JCM. 43.9.4680-4683.2005","journal-title":"J Clin Microbiol"},{"issue":"6597","key":"6147_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/383219a0","volume":"383","author":"J Davies","year":"1996","unstructured":"Davies J (1996) Bacteria on the rampage. Nature 383(6597):219\u2013220. doi: 10.1038\/383219a0","journal-title":"Nature"},{"key":"6147_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1471-2180-14-118","volume":"14","author":"PM Abreu de","year":"2014","unstructured":"de Abreu PM, Farias PG, Paiva GS, Almeida AM, Morais PV (2014) Persistence of microbial communities including Pseudomonas aeruginosa in a hospital environment: a potential health hazard. BMC Microbiol 14:118. doi: 10.1186\/1471-2180-14-118","journal-title":"BMC Microbiol"},{"issue":"4","key":"6147_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ymeth.2009.03.025","volume":"49","author":"J Campo del","year":"2009","unstructured":"del Campo J, Zayas C, Romeu B, Acevedo R, Gonzalez E, Bracho G, Cuello M, Cabrera O, Balboa J, Lastre M (2009) Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses. Methods 49(4):301\u2013308. doi: 10.1016\/j.ymeth.2009.03.025","journal-title":"Methods"},{"issue":"3","key":"6147_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2165\/00003495-200767030-00003","volume":"67","author":"JA Driscoll","year":"2007","unstructured":"Driscoll JA, Brody SL, Kollef MH (2007) The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67(3):351\u2013368. doi: 10.2165\/00003495-200767030-00003","journal-title":"Drugs"},{"issue":"1","key":"6147_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0928-8244(03)00176-7","volume":"39","author":"ML Dunkley","year":"2003","unstructured":"Dunkley ML, Rajyaguru S, McCue A, Cripps AW, Kyd JM (2003) Pseudomonas aeruginosa-specific IgG1 and IgG2 subclasses in enhancement of pulmonary clearance following passive immunisation in the rat. Fems Immunol Med Mic 39(1):37\u201344. doi: 10.1016\/S0928-8244(03)00176-7","journal-title":"Fems Immunol Med Mic"},{"key":"6147_CR16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4757-9966-8_31","volume":"417","author":"AJ Engering","year":"1997","unstructured":"Engering AJ, Cella M, Fluitsma DM, Hoefsmit EC, Lanzavecchia A, Pieters J (1997) Mannose receptor mediated antigen uptake and presentation in human dendritic cells. Adv Exp Med Biol 417:183\u2013187","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"6147_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1006\/bulm.1998.0074","volume":"61","author":"MA Fishman","year":"1999","unstructured":"Fishman MA, Perelson AS (1999) Th1\/Th2 differentiation and cross-regulation. B Math Biol 61(3):403\u2013436. doi: 10.1006\/bulm.1998.0074","journal-title":"B Math Biol"},{"issue":"1","key":"6147_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijpharm.2005.09.013","volume":"307","author":"E Gavini","year":"2006","unstructured":"Gavini E, Hegge AB, Rassu G, Sanna V, Testa C, Pirisino G, Karlsen J, Giunchedi P (2006) Nasal administration of carbamazepine using chitosan microspheres: in vitro\/in vivo studies. Int J Pharm 307(1):9\u201315. doi: 10.1016\/j.ijpharm.2005.09.013","journal-title":"Int J Pharm"},{"issue":"1","key":"6147_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2478\/v10035-012-0002-7","volume":"84","author":"J Glik","year":"2012","unstructured":"Glik J, Kawecki M, Gazdzik T, Nowak M (2012) The impact of the types of microorganisms isolated from blood and wounds on the results of treatment in burn patients with sepsis. Pol Przegl Chir 84(1):6\u201316. doi: 10.2478\/v10035-012-0002-7","journal-title":"Pol Przegl Chir"},{"issue":"2\u20133","key":"6147_CR20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0928-8244(03)00094-4","volume":"37","author":"K Gocke","year":"2003","unstructured":"Gocke K, Baumann U, Hagemann H, Gabelsberger J, Hahn H, Freihorst J, von Specht BU (2003) Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. a mucosal booster schedule. FEMS Immunol Med Microbiol 37(2\u20133):167\u2013171","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"6147_CR21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/IAI.42.1.170-177.1983","volume":"42","author":"RE Hancock","year":"1983","unstructured":"Hancock RE, Mutharia LM, Chan L, Darveau RP, Speert DP, Pier GB (1983) Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun 42(1):170\u2013177","journal-title":"Infect Immun"},{"issue":"2","key":"6147_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1751-7915.2011.00284.x","volume":"5","author":"S Hansen","year":"2012","unstructured":"Hansen S, Lehr CM (2012) Nanoparticles for transcutaneous vaccination. Microb Biotechnol 5(2):156\u2013167. doi: 10.1111\/j.1751-7915.2011.00284.x","journal-title":"Microb Biotechnol"},{"issue":"3","key":"6147_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1021\/bc060186c","volume":"18","author":"D Horak","year":"2007","unstructured":"Horak D, Babic M, Jendelova P, Herynek V, Trchova M, Pientka Z, Pollert E, Hajek M, Sykova E (2007) D-mannose-modified iron oxide nanoparticles for stem cell labeling. Bioconjug Chem 18(3):635\u2013644. doi: 10.1021\/bc060186c","journal-title":"Bioconjug Chem"},{"issue":"1","key":"6147_CR24","first-page":"17SS","volume":"35","author":"TC Horan","year":"1986","unstructured":"Horan TC, White JW, Jarvis WR, Emori TG, Culver DH, Munn VP, Thornsberry C, Olson DR, Hughes JM (1986) Nosocomial infection surveillance, 1984. MMWR CDC Surveill Summ 35(1):17SS\u201329SS","journal-title":"MMWR CDC Surveill Summ"},{"issue":"1","key":"6147_CR25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0378-1119(89)90359-4","volume":"77","author":"RM Horton","year":"1989","unstructured":"Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR (1989) Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77(1):61\u201368","journal-title":"Gene"},{"issue":"1\u20133","key":"6147_CR26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00171-5","volume":"51","author":"L Illum","year":"2001","unstructured":"Illum L, Jabbal-Gill I, Hinchcliffe M, Fisher AN, Davis SS (2001) Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev 51(1\u20133):81\u201396","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"6147_CR27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1517\/17425247.5.6.703","volume":"5","author":"JM Irache","year":"2008","unstructured":"Irache JM, Salman HH, Gamazo C, Espuelas S (2008) Mannose-targeted systems for the delivery of therapeutics. Expert Opin Drug Del 5(6):703\u2013724. doi: 10.1517\/17425247.5.6.703","journal-title":"Expert Opin Drug Del"},{"issue":"3","key":"6147_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ejpb.2004.05.006","volume":"58","author":"HL Jiang","year":"2004","unstructured":"Jiang HL, Park IK, Shin NR, Kang SG, Yoo HS, Kim SI, Suh SB, Akaike T, Cho CS (2004) In vitro study of the immune stimulating activity of an atrophic [correction of athrophic] rhinitis vaccine associated to chitosan microspheres. Eur J Pharm Biopharm 58(3):471\u2013476. doi: 10.1016\/j.ejpb.2004.05.006","journal-title":"Eur J Pharm Biopharm"},{"issue":"12","key":"6147_CR29","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.biomaterials.2007.12.025","volume":"29","author":"HL Jiang","year":"2008","unstructured":"Jiang HL, Kang ML, Quan JS, Kang SG, Akaike T, Yoo HS, Cho CS (2008) The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization. Biomaterials 29(12):1931\u20131939. doi: 10.1016\/j.biomaterials.2007.12.025","journal-title":"Biomaterials"},{"issue":"7","key":"6147_CR30","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.biomaterials.2013.11.073","volume":"35","author":"T Jiang","year":"2014","unstructured":"Jiang T, Singh B, Li HS, Kim YK, Kang SK, Nah JW, Choi YJ, Cho CS (2014) Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan. Biomaterials 35(7):2365\u20132373. doi: 10.1016\/j.biomaterials.2013.11.073","journal-title":"Biomaterials"},{"key":"6147_CR31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0463.1996.tb05581.x","volume":"63","author":"HK Johansen","year":"1996","unstructured":"Johansen HK (1996) Potential of preventing Pseudomonas aeruginosa lung infections in cystic fibrosis patients: experimental studies in animals. APMIS Suppl 63:5\u201342","journal-title":"APMIS Suppl"},{"key":"6147_CR32","doi-asserted-by":"publisher","DOI":"10.1159\/000365399","author":"S Jovic","year":"2014","unstructured":"Jovic S, Shikhagaie M, Morgelin M, Kjellstrom S, Erjefalt J, Olin AI, Frick IM, Egesten A (2014) Expression of MIG\/CXCL9 in cystic fibrosis and modulation of its activities by elastase of Pseudomonas aeruginosa. J Innate Immun. doi: 10.1159\/000365399","journal-title":"J Innate Immun"},{"issue":"23","key":"6147_CR33","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1016\/j.vaccine.2007.03.038","volume":"25","author":"ML Kang","year":"2007","unstructured":"Kang ML, Jiang HL, Kang SG, Guo DD, Lee DY, Cho CS, Yoo HS (2007) Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin. Vaccine 25(23):4602\u20134610. doi: 10.1016\/j.vaccine.2007.03.038","journal-title":"Vaccine"},{"issue":"6","key":"6147_CR34","first-page":"1179","volume":"18","author":"ML Kang","year":"2008","unstructured":"Kang ML, Kang SG, Jiang HL, Gu DD, Lee DY, Rayamahji N, Seo YS, Ch CS, Yoo HS (2008) Chitosan microspheres containing Bordetella bronchiseptica antigens as novel vaccine against atrophic rhinitis in pigs. J Microbiol Biotechn 18(6):1179\u20131185","journal-title":"J Microbiol Biotechn"},{"issue":"12","key":"6147_CR35","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1517\/14712598.4.12.1953","volume":"4","author":"T Keler","year":"2004","unstructured":"Keler T, Ramakrishna V, Fanger MW (2004) Mannose receptor-targeted vaccines. Expert Opin Biol Ther 4(12):1953\u20131962. doi: 10.1517\/14712598.4.12.1953","journal-title":"Expert Opin Biol Ther"},{"key":"6147_CR36","first-page":"349","volume":"82","author":"B Knapp","year":"1988","unstructured":"Knapp B, Shaw A, Hundt E, Enders B, Kupper HA (1988) A histidin alanine rich recombinant antigen protects Aotus monkeys from P. falciparum infection. Behring Inst Mitt 82:349\u2013359","journal-title":"Behring Inst Mitt"},{"issue":"13\u201314","key":"6147_CR37","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0264-410X(98)00420-4","volume":"17","author":"B Knapp","year":"1999","unstructured":"Knapp B, Hundt E, Lenz U, Hungerer KD, Gabelsberger J, Domdey H, Mansouri E, Li Y, von Specht BU (1999) A recombinant hybrid outer membrane protein for vaccination against Pseudomonas aeruginosa. Vaccine 17(13\u201314):1663\u20131666","journal-title":"Vaccine"},{"issue":"11","key":"6147_CR38","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.vaccine.2010.12.087","volume":"29","author":"A Krause","year":"2011","unstructured":"Krause A, Whu WZ, Xu Y, Joh J, Crystal RG, Worgall S (2011) Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF. Vaccine 29(11):2131\u20132139. doi: 10.1016\/j.vaccine.2010.12.087","journal-title":"Vaccine"},{"issue":"17\u201319","key":"6147_CR39","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0264-410X(00)00550-8","volume":"19","author":"M Larbig","year":"2001","unstructured":"Larbig M, Mansouri E, Freihorst J, Tummler B, Kohler G, Domdey H, Knapp B, Hungerer KD, Hundt E, Gabelsberger J, von Specht BU (2001) Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers. Vaccine 19(17\u201319):2291\u20132297","journal-title":"Vaccine"},{"issue":"8","key":"6147_CR40","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/Nri3251","volume":"12","author":"N Lycke","year":"2012","unstructured":"Lycke N (2012) Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 12(8):592\u2013605. doi: 10.1038\/Nri3251","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"6147_CR41","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1128\/IAI.67.3.1461-1470.1999","volume":"67","author":"E Mansouri","year":"1999","unstructured":"Mansouri E, Gabelsberger J, Knapp B, Hundt E, Lenz U, Hungerer KD, Gilleland HE, Staczek J, Domdey H, von Specht BU (1999) Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers. Infect Immun 67(3):1461\u20131470","journal-title":"Infect Immun"},{"issue":"2\u20133","key":"6147_CR42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0928-8244(03)00072-5","volume":"37","author":"E Mansouri","year":"2003","unstructured":"Mansouri E, Blome-Eberwein S, Gabelsberger J, Germann G, von Specht BU (2003) Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients. FEMS Immunol Med Microbiol 37(2\u20133):161\u2013166","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"6147_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1751-7915.2011.00316.x","volume":"5","author":"UB Mayr","year":"2012","unstructured":"Mayr UB, Kudela P, Atrasheuskaya A, Bukin E, Ignatyev G, Lubitz W (2012) Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge. Microb Biotechnol 5(2):283\u2013294. doi: 10.1111\/j.1751-7915.2011.00316.x","journal-title":"Microb Biotechnol"},{"issue":"9\u201310","key":"6147_CR44","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/S0264-410x(00)00309-1","volume":"19","author":"EA McNeela","year":"2000","unstructured":"McNeela EA, O\u2019Connor D, Jabbal-Gill I, Illum L, Davis SS, Pizza M, Peppoloni S, Rappuoli R, Mills KHG (2000) A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery. Vaccine 19(9\u201310):1188\u20131198. doi: 10.1016\/S0264-410x(00)00309-1","journal-title":"Vaccine"},{"issue":"8","key":"6147_CR45","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.vaccine.2003.09.012","volume":"22","author":"EA McNeela","year":"2004","unstructured":"McNeela EA, Jabbal-Gill I, Illum L, Pizza M, Rappuoli R, Podda A, Lewis DJ, Mills KH (2004) Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan. Vaccine 22(8):909\u2013914. doi: 10.1016\/j.vaccine.2003.09.012","journal-title":"Vaccine"},{"key":"6147_CR46","volume-title":"Selected methods in cellular immunology","author":"BB Mishell","year":"1980","unstructured":"Mishell BB, Shiigi SM (1980) Selected methods in cellular immunology. W. H. Freeman, San Francisco"},{"issue":"14","key":"6147_CR47","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.7314\/APJCP.2014.15.14.5787","volume":"15","author":"SA Park","year":"2014","unstructured":"Park SA, Cho SS, Kwak GJ (2014) Factors influencing ventilator-associated pneumonia in cancer patients. Asian Pac J Cancer Prev 15(14):5787\u20135791","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"6147_CR48","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/CMR.11.4.589","volume":"11","author":"R Podschun","year":"1998","unstructured":"Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11(4):589\u2013603","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"6147_CR49","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1128\/JCM.36.8.2331-2332.1998","volume":"36","author":"R Podschun","year":"1998","unstructured":"Podschun R, Acktun H, Okpara J, Linderkamp O, Ullmann U, Borneff-Lipp M (1998) Isolation of Klebsiella planticola from newborns in a neonatal ward. J Clin Microbiol 36(8):2331\u20132332","journal-title":"J Clin Microbiol"},{"issue":"2","key":"6147_CR50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002689900361","volume":"22","author":"BA Pruitt Jr","year":"1998","unstructured":"Pruitt BA Jr, McManus AT, Kim SH, Goodwin CW (1998) Burn wound infections: current status. World J Surg 22(2):135\u2013145","journal-title":"World J Surg"},{"issue":"5","key":"6147_CR51","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.4049\/jimmunol.172.5.2845","volume":"172","author":"V Ramakrishna","year":"2004","unstructured":"Ramakrishna V, Treml JF, Vitale L, Connolly JE, O\u2019Neill T, Smith PA, Jones CL, He LZ, Goldstein J, Wallace PK, Keler T, Endres MJ (2004) Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules. J Immunol 172(5):2845\u20132852","journal-title":"J Immunol"},{"issue":"8","key":"6147_CR52","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0264-410X(96)00249-6","volume":"15","author":"HL Robinson","year":"1997","unstructured":"Robinson HL (1997) Nucleic acid vaccines: an overview. Vaccine 15(8):785\u2013787","journal-title":"Vaccine"},{"key":"6147_CR53","volume-title":"Encyclopedia of immunology","author":"IM Roitt","year":"1992","unstructured":"Roitt IM, Delves PJ (1992) Encyclopedia of immunology. Academic, London"},{"key":"6147_CR54","volume-title":"Immunology","author":"IM Roitt","year":"2001","unstructured":"Roitt IM, Brostoff J, Male DK (2001) Immunology, 6th edn. Mosby Inc, Edinburgh","edition":"6"},{"issue":"2","key":"6147_CR55","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.182.2.389","volume":"182","author":"F Sallusto","year":"1995","unstructured":"Sallusto F, Cella M, Danieli C, Lanzavecchia A (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182(2):389\u2013400","journal-title":"J Exp Med"},{"issue":"9\u201310","key":"6147_CR56","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1166\/jnn.2006.445","volume":"6","author":"HH Salman","year":"2006","unstructured":"Salman HH, Gamazo C, Campanero MA, Irache JM (2006) Bioadhesive mannosylated nanoparticles for oral drug delivery. J Nanosci Nanotechnol 6(9\u201310):3203\u20133209","journal-title":"J Nanosci Nanotechnol"},{"issue":"4","key":"6147_CR57","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s15010-014-0635-z","volume":"42","author":"G Samonis","year":"2014","unstructured":"Samonis G, Vardakas KZ, Kofteridis DP, Dimopoulou D, Andrianaki AM, Chatzinikolaou I, Katsanevaki E, Maraki S, Falagas ME (2014) Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections. Infection 42(4):721\u2013728. doi: 10.1007\/s15010-014-0635-z","journal-title":"Infection"},{"issue":"30","key":"6147_CR58","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.2174\/0929867321666140826115552","volume":"21","author":"B Sedaghat","year":"2014","unstructured":"Sedaghat B, Stephenson R, Toth I (2014) Targeting the mannose receptor with mannosylated subunit vaccines. Curr Med Chem 21(30):3405\u20133418","journal-title":"Curr Med Chem"},{"issue":"10","key":"6147_CR59","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4161\/hv.7.10.16369","volume":"7","author":"A Sharma","year":"2011","unstructured":"Sharma A, Krause A, Worgall S (2011) Recent developments for Pseudomonas vaccines. Hum Vaccin 7(10):999\u20131011. doi: 10.4161\/hv.7.10.16369","journal-title":"Hum Vaccin"},{"issue":"2","key":"6147_CR60","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1751-7915.2011.00321.x","volume":"5","author":"A Six","year":"2012","unstructured":"Six A, Bellier B, Thomas-Vaslin V, Klatzmann D (2012) Systems biology in vaccine design. Microb Biotechnol 5(2):295\u2013304. doi: 10.1111\/j.1751-7915.2011.00321.x","journal-title":"Microb Biotechnol"},{"issue":"1","key":"6147_CR61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0378-1119(88)90005-4","volume":"67","author":"DB Smith","year":"1988","unstructured":"Smith DB, Johnson KS (1988) Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67(1):31\u201340","journal-title":"Gene"},{"issue":"21","key":"6147_CR62","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1016\/j.vaccine.2009.03.010","volume":"27","author":"S Sorichter","year":"2009","unstructured":"Sorichter S, Baumann U, Baumgart A, Walterspacher S, von Specht BU (2009) Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung disease. Vaccine 27(21):2755\u20132759. doi: 10.1016\/j.vaccine.2009.03.010","journal-title":"Vaccine"},{"key":"6147_CR63","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4757-9966-8_28","volume":"417","author":"MC Tan","year":"1997","unstructured":"Tan MC, Mommaas AM, Drijfhout JW, Jordens R, Onderwater JJ, Verwoerd D, Mulder AA, van der Heiden AN, Ottenhoff TH, Cella M, Tulp A, Neefjes JJ, Koning F (1997) Mannose receptor mediated uptake of antigens strongly enhances HLA-class II restricted antigen presentation by cultured dendritic cells. Adv Exp Med Biol 417:171\u2013174","journal-title":"Adv Exp Med Biol"},{"key":"6147_CR64","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1107\/S1399004714001850","volume":"70","author":"JQ Tan","year":"2014","unstructured":"Tan JQ, Rouse SL, Li DF, Pye VE, Vogeley L, Brinth AR, El Arnaout T, Whitney JC, Howell PL, Sansom MSP, Caffrey M (2014) A conformational landscape for alginate secretion across the outer membrane of Pseudomonas aeruginosa. Acta Crystallogr D 70:2054\u20132068. doi: 10.1107\/S1399004714001850","journal-title":"Acta Crystallogr D"},{"issue":"4","key":"6147_CR65","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.carbpol.2010.10.051","volume":"83","author":"S Taranejoo","year":"2011","unstructured":"Taranejoo S, Janmaleki M, Rafienia M, Kamali M, Mansouri M (2011) Chitosan microparticles loaded with exotoxin A subunit antigen for intranasal vaccination against Pseudomonas aeruginosa: an in vitro study. Carbohyd Polym 83(4):1854\u20131861. doi: 10.1016\/j.carbpol.2010.10.051","journal-title":"Carbohyd Polym"},{"key":"6147_CR66","unstructured":"Tummler B, Bosshammer J, Breitenstein S, Brockhausen I, Gudowius P, Herrmann C, Herrmann S, Heuer T, Kubesch P, Mekus F, Romling U, Schmidt KD, Spangenberg C, Walter S (1997) Infections with Pseudomonas aeruginosa in patients with cystic fibrosis. Behring Inst Mitt (98):249\u201355"},{"issue":"7","key":"6147_CR67","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/02652040400015403","volume":"21","author":"J Varshosaz","year":"2004","unstructured":"Varshosaz J, Sadrai H, Alinagari R (2004) Nasal delivery of insulin using chitosan microspheres. J Microencapsul 21(7):761\u2013774. doi: 10.1080\/02652040400015403","journal-title":"J Microencapsul"},{"issue":"6","key":"6147_CR68","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0196-6553(97)90067-5","volume":"25","author":"E Velasco","year":"1997","unstructured":"Velasco E, Thuler LC, Martins CA, Dias LM, Goncalves VM (1997) Nosocomial infections in an oncology intensive care unit. Am J Infect Control 25(6):458\u2013462","journal-title":"Am J Infect Control"},{"key":"6147_CR69","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.scitotenv.2014.08.041","volume":"499C","author":"S Vincenti","year":"2014","unstructured":"Vincenti S, Quaranta G, De Meo C, Bruno S, Ficarra MG, Carovillano S, Ricciardi W, Laurenti P (2014) Non-fermentative gram-negative bacteria in hospital tap water and water used for haemodialysis and bronchoscope flushing: prevalence and distribution of antibiotic resistant strains. Sci Total Environ 499C:47\u201354. doi: 10.1016\/j.scitotenv.2014.08.041","journal-title":"Sci Total Environ"},{"issue":"5","key":"6147_CR70","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/IAI.63.5.1855-1862.1995","volume":"63","author":"BU Specht von","year":"1995","unstructured":"von Specht BU, Knapp B, Muth G, Broker M, Hungerer KD, Diehl KD, Massarrat K, Seemann A, Domdey H (1995) Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins. Infect Immun 63(5):1855\u20131862","journal-title":"Infect Immun"},{"key":"6147_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2014.04.007","author":"N Wang","year":"2014","unstructured":"Wang N, Wang T, Zhang M, Chen R, Niu R, Deng Y (2014) Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system. Eur J Pharm Biopharm. doi: 10.1016\/j.ejpb.2014.04.007","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"6147_CR72","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1586\/Erv.09.61","volume":"8","author":"Y Yuki","year":"2009","unstructured":"Yuki Y, Kiyono H (2009) Mucosal vaccines: novel advances in technology and delivery. Expert Rev Vaccines 8(8):1083\u20131097. doi: 10.1586\/Erv.09.61","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"6147_CR73","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.vaccine.2006.11.034","volume":"25","author":"DA Zaharoff","year":"2007","unstructured":"Zaharoff DA, Rogers CJ, Hance KW, Schlom J, Greiner JW (2007) Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine 25(11):2085\u20132094. doi: 10.1016\/j.vaccine.2006.11.034","journal-title":"Vaccine"},{"issue":"4","key":"6147_CR74","first-page":"692","volume":"47","author":"RL Zhai","year":"2007","unstructured":"Zhai RL, Xu HY, Wang YL, Qin ZM, Jiang SJ (2007) Study on immune efficacy of Newcastle disease chitosan microsphere vaccine. Wei Sheng Wu Xue Bao 47(4):692\u2013696","journal-title":"Wei Sheng Wu Xue Bao"},{"issue":"3","key":"6147_CR75","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jconrel.2007.05.018","volume":"121","author":"X Zhou","year":"2007","unstructured":"Zhou X, Liu B, Yu X, Zha X, Zhang X, Chen Y, Wang X, Jin Y, Wu Y, Chen Y, Shan Y, Chen Y, Liu J, Kong W, Shen J (2007) Controlled release of PEI\/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine. J Control Release 121(3):200\u2013207. doi: 10.1016\/j.jconrel.2007.05.018","journal-title":"J Control Release"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-014-6147-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-014-6147-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-014-6147-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-014-6147-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T20:32:35Z","timestamp":1598473955000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-014-6147-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,11]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["6147"],"URL":"https:\/\/doi.org\/10.1007\/s00253-014-6147-z","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,11]]}}}